Press Releases about INmune Bio Inc. - Common stock![]()
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans
January 28, 2025
From INmune Bio, Inc.
Via GlobeNewswire
![]()
INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt
December 10, 2024
From INmune Bio, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() From INmune Bio, Inc.
Via GlobeNewswire
![]() ![]() ![]() From INmune Bio, Inc.
Via GlobeNewswire
![]()
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
September 30, 2024
From INmune Bio, Inc.
Via GlobeNewswire
![]() ![]() ![]()
INmune Bio Announces $13.0 Million Registered Direct Offering
September 13, 2024
From INmune Bio, Inc.
Via GlobeNewswire
![]()
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
September 03, 2024
From INmune Bio, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|